Swallowing changes and causes of swallowing problems in Alzheimer's disease
Official title: Swallowing Trajectories and DysPHagia Predictors in AlzheimER’s DisEase (SPHERE)
Funded at University of Wisconsin-Madison · NIH-11321295 · Data updated 2026-11-12
Following people with Alzheimer's over time to understand how their swallowing changes and what factors lead to swallowing problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | May 15, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $743,081 |
| NIH project number | 5R01AG082170-04 |
| Project ID | NIH-11321295 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults diagnosed with Alzheimer's disease or related dementias, including those in early stages who can travel to clinic visits and complete swallowing tests, are ideal candidates.
✕Less likely to help
People without Alzheimer's or related dementias, or those who are too medically unstable or too severely impaired to complete the swallowing evaluations, are unlikely to benefit from this study.
What this research studies
I would join a group of people with Alzheimer's disease or related dementias who are followed over several years to track swallowing function as the disease progresses. Researchers will use detailed, multi‑modal swallowing tests, clinical exams, and caregiver reports to look for early or subtle changes in how people swallow. Participants will be grouped by disease stage so doctors can compare patterns from early to later stages. The team hopes to identify factors that predict swallowing decline and point to times when treatments could help prevent weight loss, pneumonia, and reduced quality of life.
Why it matters
Potential benefit: If successful, this work could help doctors spot swallowing problems earlier and guide therapies that reduce choking, malnutrition, and pneumonia.
How similar studies have gone: Small cross-sectional studies have shown early swallowing changes in Alzheimer's and rehabilitative treatments helped other neurodegenerative conditions, but this comprehensive longitudinal approach in AD/ADRD is relatively new.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Rogus-Pulia, Nicole M — University of Wisconsin-Madison
- Study coordinator: Rogus-Pulia, Nicole M
Related research
Other NIH-funded projects on the same topics.
-
Understanding swallowing difficulties in Alzheimer's disease
This study is looking at the swallowing problems that people with Alzheimer's and similar conditions often face, to understand what causes these issues and how they change over time, so we can find better ways to help manage them and prevent serious health problems.
-
Evaluating and predicting swallowing improvement in hospitalized Alzheimer's patients
This study is looking at how to help patients with Alzheimer's and related dementias who have trouble swallowing, by using a special computer program to predict which patients might get better before they leave the hospital, so that doctors can give them the best care and diet to improve their eating and overall well-b
-
Engaging underrepresented individuals with Alzheimer's disease in swallowing research
This study is looking for ways to help people with Alzheimer's and related dementias who have trouble swallowing by teaming up with community groups to make sure everyone gets a chance to participate, so we can find better treatments that improve their swallowing and overall well-being.
-
Improving swallowing function in patients with Alzheimer's and related dementias
This study is looking for new ways to help people with Alzheimer's and related dementias who have trouble swallowing, by training a speech therapist to create better treatments that can make eating and drinking safer and easier for them.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.